A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF ROZANOLIXIZUMAB IN ADULT STUDY PARTICIPANTS WITH LEUCINE-RICH GLIOMA INACTIVATED 1 AUTOIMMUNE ENCEPHALITIS

Project: Research

Project Details

StatusFinished
Effective start/end date24/08/21 → 31/12/24

Keywords

  • Autoimmune encephalitis
  • Neurology
  • Neurosciences
  • Clinical trial